Get the Stockscreener App
4.2265
1.24%
0.0165
Olema Pharmaceuticals Inc Stock (OLMA) Forecast
The Olema Pharmaceuticals Inc (OLMA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.5858, representing a -15.16% decrease from the current price of $4.2265. The highest analyst price target is $2.6008, and the lowest is $4.5708.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OLMA Price Target
Average 14.24
(+236.95% Upside)
Is Olema Pharmaceuticals Inc (OLMA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.63 | Neutral |
| STOCH(9,6) | 75.12 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.1471 | Buy |
| ADX(14) | 27.36 | Buy |
| William %R | -3.4483 | Sell |
| CCI(14) | 80.84 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.57
Buy
|
3.8061
Buy
|
| MA20 |
3.772
Buy
|
3.8465
Buy
|
| MA50 |
4.3754
Sell
|
4.4682
Sell
|
| MA100 |
5.6678
Sell
|
5.8095
Sell
|
| MA200 |
9.0077
Sell
|
7.7356
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, OLMA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on OLMA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 57.63 indicates that OLMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 75.12 indicates that OLMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that OLMA is oversold. This suggests that OLMA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.36 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 80.84 indicates that OLMA is still overbought but not to an extreme extent.
Long-term OLMA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Olema Pharmaceuticals Inc financial reports and earnings history, Olema Pharmaceuticals Inc (OLMA) stock could reach $46.98 by 2030, $148.26 by 2040 and $149.30 by 2050. See the projected annual prices until 2050 of the Olema Pharmaceuticals Inc stock below:
- Olema Pharmaceuticals Inc (OLMA) is expected to reach an average price of $39.49 in 2035, with a high prediction of $44.51 and a low estimate of $40.67. This indicates an $834.38% rise from the last recorded price of $4.2265.
- Olema Pharmaceuticals Inc (OLMA) stock is projected to chart a bullish course in 2040, with an average price target of $149.94, representing an $3,448% surge from its current level. The forecast ranges from a conservative $147.03 to a sky-high $148.26.
- Our analysts predict Olema Pharmaceuticals Inc (OLMA) to jump 3,942% by 2045, soaring from $171.59 to an average price of $170.85, potentially reaching $171.62. While $171.59 is the low estimate, the potential upside is significant.
- Olema Pharmaceuticals Inc (OLMA) stock is expected to climb by 2050, reaching an average of $146.71, a $3,371% jump from its current level. However, a wide range of estimates exists, with high and low targets of $149.30 and $147.01, respectively, highlighting the market's uncertainty.
Olema Pharmaceuticals Inc Stock (OLMA) Year by Year Forecast
Olema Pharmaceuticals Inc Stock (OLMA) Price Forecast for 2025
Olema Pharmaceuticals Inc Stock (OLMA) is expected to reach an average price of $13.66 in 2025, with a high prediction of $23.91 and a low estimate of $3.3995. This indicates an +223.09% rise from the last recorded price of $4.2265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $3.9758 | $4.5708 | $2.6008 | -5.93% |
| June, 2025 | $19.91 | $10.05 | $19.69 | +371.18% |
| July, 2025 | $22.32 | $20.43 | $19.95 | +428.11% |
| August, 2025 | $22.58 | $23.11 | $22.74 | +434.23% |
| September, 2025 | $23.80 | $23.26 | $23.63 | +463.07% |
| October, 2025 | $23.16 | $23.17 | $23.47 | +448.07% |
| November, 2025 | $23.94 | $23.27 | $23.34 | +466.50% |
| December, 2025 | $24.00 | $24.12 | $23.91 | +467.82% |
Olema Pharmaceuticals Inc Stock (OLMA) Price Forecast for 2026
The predicted value for Olema Pharmaceuticals Inc (OLMA) in 2026 is set at an average of $19.02. Estimates vary from a peak of $23.09 to a trough of $14.95, indicating an +349.96% surge from the present price of $4.2265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $21.34 | $22.39 | $23.09 | +404.97% |
| February, 2026 | $20.86 | $21.05 | $21.48 | +393.47% |
| March, 2026 | $19.41 | $20.00 | $19.85 | +359.13% |
| April, 2026 | $19.71 | $19.46 | $19.60 | +366.37% |
| May, 2026 | $20.19 | $19.47 | $19.51 | +377.70% |
| June, 2026 | $18.94 | $19.74 | $19.89 | +348.10% |
| July, 2026 | $19.04 | $18.51 | $18.34 | +350.60% |
| August, 2026 | $18.62 | $18.62 | $18.36 | +340.64% |
| September, 2026 | $16.15 | $17.53 | $18.26 | +282.10% |
| October, 2026 | $15.14 | $15.29 | $15.31 | +258.18% |
| November, 2026 | $14.98 | $15.19 | $14.84 | +254.36% |
| December, 2026 | $14.84 | $14.95 | $14.69 | +251.19% |
Olema Pharmaceuticals Inc Stock (OLMA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Olema Pharmaceuticals Inc (OLMA) is $7.2495, with a high forecast of $14.49 and a low forecast of $0.00857. This indicates an +71.52% increase from the last price of $4.2265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $12.91 | $13.77 | $14.49 | +205.50% |
| February, 2027 | $11.84 | $10.98 | $10.65 | +180.15% |
| March, 2027 | $8.4567 | $8.6467 | $11.45 | +100.09% |
| April, 2027 | $6.4655 | $7.6711 | $6.6661 | +52.97% |
| May, 2027 | $4.6243 | $6.1543 | $6.7499 | +9.41% |
| June, 2027 | $2.6702 | $4.1295 | $4.7887 | -36.82% |
| July, 2027 | $1.019 | $2.0218 | $0.819 | -75.89% |
| August, 2027 | $0.1722 | $1.9278 | $0.7634 | -95.93% |
| September, 2027 | $1.5962 | $0.1351 | $4.9789 | -62.23% |
| October, 2027 | $2.0374 | $0.2662 | $3.5018 | -51.79% |
| November, 2027 | $0.1486 | $0.217 | $3.8502 | -96.48% |
| December, 2027 | $4.6226 | $0.00857 | $6.4076 | +9.37% |
Olema Pharmaceuticals Inc Stock (OLMA) Price Forecast for 2028
In 2028, Olema Pharmaceuticals Inc (OLMA) is projected to reach an average price of $22.84, with a high projection of $45.16 and a low estimate of $0.5107. This indicates an +440.34% rise from the last price of $4.2265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.2439 | $1.8782 | $5.5639 | -23.25% |
| February, 2028 | $1.5551 | $1.1995 | $4.1867 | -63.21% |
| March, 2028 | $1.6243 | $0.5107 | $2.7379 | -61.57% |
| April, 2028 | $34.60 | $29.28 | $27.88 | +718.72% |
| May, 2028 | $34.57 | $31.20 | $33.28 | +717.82% |
| June, 2028 | $27.53 | $27.71 | $30.21 | +551.43% |
| July, 2028 | $26.79 | $27.96 | $32.82 | +533.86% |
| August, 2028 | $39.54 | $30.50 | $39.71 | +835.58% |
| September, 2028 | $49.56 | $38.67 | $42.82 | +1,073% |
| October, 2028 | $42.23 | $43.84 | $45.16 | +899.11% |
| November, 2028 | $41.74 | $41.00 | $40.19 | +887.56% |
| December, 2028 | $43.71 | $43.93 | $41.32 | +934.12% |
Olema Pharmaceuticals Inc Stock (OLMA) Price Forecast for 2029
The 2029 price forecast for Olema Pharmaceuticals Inc Stock (OLMA) is $43.80 on average, with a high prediction of $52.03 and a low estimate of $35.57. This represents an +936.23% increase from the previous price of $4.2265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $35.74 | $36.23 | $40.57 | +745.59% |
| February, 2029 | $35.97 | $36.25 | $35.19 | +750.98% |
| March, 2029 | $32.48 | $36.34 | $34.55 | +668.58% |
| April, 2029 | $34.97 | $35.57 | $33.63 | +727.44% |
| May, 2029 | $50.24 | $40.90 | $50.08 | +1,089% |
| June, 2029 | $51.94 | $50.46 | $49.58 | +1,129% |
| July, 2029 | $51.59 | $52.12 | $51.90 | +1,121% |
| August, 2029 | $51.81 | $52.11 | $52.03 | +1,126% |
| September, 2029 | $50.80 | $50.81 | $50.90 | +1,102% |
| October, 2029 | $50.89 | $50.60 | $50.37 | +1,104% |
| November, 2029 | $50.26 | $50.45 | $50.35 | +1,089% |
| December, 2029 | $46.99 | $48.04 | $49.19 | +1,012% |
Olema Pharmaceuticals Inc Stock (OLMA) Price Forecast for 2030
Olema Pharmaceuticals Inc Stock (OLMA) is expected to reach an average price of $39.23 in 2030, with a high forecast of $46.98 and a low forecast of $31.47. This signifies an +828.12% surge from the last price of $4.2265.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $44.94 | $45.67 | $46.98 | +963.23% |
| February, 2030 | $42.66 | $43.73 | $44.56 | +909.46% |
| March, 2030 | $43.37 | $43.49 | $43.57 | +926.20% |
| April, 2030 | $43.24 | $42.68 | $43.02 | +923.07% |
| May, 2030 | $40.86 | $41.24 | $42.79 | +866.81% |
| June, 2030 | $40.72 | $40.65 | $40.40 | +863.44% |
| July, 2030 | $39.49 | $39.54 | $39.88 | +834.38% |
| August, 2030 | $36.45 | $37.83 | $38.69 | +762.40% |
| September, 2030 | $34.83 | $34.98 | $35.45 | +724.01% |
| October, 2030 | $33.75 | $34.08 | $33.96 | +698.50% |
| November, 2030 | $33.16 | $33.26 | $33.21 | +684.49% |
| December, 2030 | $30.61 | $31.47 | $32.65 | +624.33% |
1.19%
2.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):